- Scientists and researchers focused on the stability of biopharmaceuticals, including peptides and LNPs
- Anyone involved in the development and production of nucleic acid drug products and biologics
- Gain insights into higher-order structural changes, thermal stability, and particle size distribution
- Learn how SAXS and DSC provide critical information on drug modalities
- Understand the importance of orthogonal approaches to the structure-property relationship of biopharmaceuticals
- Partnering for innovation: Learn about the collaboration between Malvern Panalytical and Xenocs and how the combination of our tools and expertise delivers innovative solutions for biophysical characterization
- Biologics Deep Dive: Explore orthogonal techniques for stability assessment of peptide-based therapeutics.
- A closer look at lipid nanoparticles (LNPs): Understand the structure and stability behavior of these complex drug delivery systems.
- Webinar 1: October 23, 2024 - Key tools for understanding drug efficacy and stability
- Webinar 2: November 20, 2024 - Complementary techniques for biophysical characterization of peptides and protein-based drug products
- Webinar 3: December 10, 2024 - Elucidating the internal structure of RNA based therapeutics and vaccines
- Higher-order structural changes and thermal stability
- Particle size distribution, aggregation propensity, polydispersity, and particle concentration
- Absolute molecular weight and molecular size
- Protein structural arrangements, including conformational states and multimer formation
- The structure and composition of lipid nanoparticles (LNPs), which are increasingly favored as drug delivery systems
Key tools for understanding drug efficacy and stability
Focus on Biopharmaceuticals series
October 23, 2024 | 15:00 - 16:00 CET | Virtual
About The Event
The development and production of biopharmaceuticals are advancing rapidly, with novel medicines becoming increasingly complex. From amorphous small molecules and fusion proteins to antibody-drug conjugates (ADCs) and viral & synthetic delivery vectors for cell & gene therapies, understanding the structure and composition of these entities is crucial for ensuring their efficacy and manufacturability. Join us for the first webinar in a three-part series as we explore the complementary analytical solutions that will give you deeper insights into the structural features of your biopharmaceuticals. Together, technology and biopharmaceuticals industry experts from Malvern Panalytical and Xenocs will dive into applications around nucleic acid drug products (such as mRNA vaccines and RNA therapeutics), as well as biopharmaceuticals including peptide-based therapeutics.
More Information
Who should attend?
What will you learn?
About the series: Focus on Biopharmaceuticals
Register for the full series today:
About the Malvern Panalytical & Xenocs collaboration
Malvern Panalytical brings decades of expertise in the characterization of (bio)pharmaceuticals, offering a suite of advanced analytical methods and instrumentation. Our technologies provide critical insights into:
As a leader in Small-Angle X-ray Scattering (SAXS), Xenocs offers state-of-the-art solutions for the structural characterization of materials at the nanoscale. By merging advanced academic techniques with industrial applications in drug development, Xenocs' instrumentation provides unmatched insights into:
Join us to explore how these advanced analytical techniques can be combined to drive innovation and ensure the success of your biopharmaceutical development efforts.
facebook twitterrssinstagramlinkedinyoutube